Tabriz Medical University
Also known as: Alireza Javadzadeh | Cardiovascular research center, Tabriz University of Medical Sciences, Tabriz, Iran | Deputy for translational medicine of SCARM institute | Farid Masoud | Head of SCARM Cell therapy Center | Head of SCARM institute | Head of SCARM Institute | liver &Gastrointestinal Research center of tabriz medical university | Pharmaceutics Department, Pharmacy Faculty | Pharmacy Faculty | SCARM institiute | SCARM institute | SCARM Institute, Tabriz, Iran | Stem Cell and Regenerative Medicine Institute | tabriz medical university | Tabriz Research Center for Gastroenterology and Liver Diseases | Tabriz university of medical science | Tabriz University of Medical Sciences
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2007Last known activity
May 1, 2025
Timeline
1940s
- Jan 1, 1947
Tabriz Medical University— Founded
Drugs by trial phase (27 distinct, 26 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (16 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Abortion, Habitual
- Abortion, Spontaneous
- Alopecia
- Alopecia Areata
- Burns
- Central Serous Chorioretinopathy
- Fetal Death
- Heart Failure
- Hemophilia A
- Hepatitis
- Hepatitis A
- Hepatitis C
- Multiple Sclerosis
- Optic Nerve Diseases
- Optic Nerve Injuries
- Osteoarthritis
- Peripheral Nervous System Diseases
- Sclerosis
- Spondylitis
- Spondylitis, Ankylosing
- Thalassemia
- Wounds and Injuries
Recent trials (50)
- NCT06840054Sponsor investigatorPhase 2May 1, 2025
- NCT06840054Lead sponsorPhase 2May 1, 2025
- NCT06809816Sponsor investigatorPhase 2Mar 1, 2025
- NCT06809816Lead sponsorPhase 2Mar 1, 2025
- NCT06523959CollaboratorPhase 4Jun 6, 2024
- NCT05741606Overall official - principal investigatorPhase 1/Phase 2Jul 21, 2023
- NCT05741606Reponsible party - principal investigatorPhase 1/Phase 2Jul 21, 2023
- NCT05741606Lead sponsorPhase 1/Phase 2Jul 21, 2023
- NCT05798455Overall official - principal investigatorPhase 1/Phase 2May 22, 2023
- NCT05798455Reponsible party - principal investigatorPhase 1/Phase 2May 22, 2023
- NCT05798455Lead sponsorPhase 1/Phase 2May 22, 2023
- NCT06469411CollaboratorPhase 3Jan 1, 2023
- NCT06469411Sponsor investigatorPhase 3Jan 1, 2023
- NCT06469411Lead sponsorPhase 3Jan 1, 2023
- NCT05098678Lead sponsorN/AAug 22, 2020
Details
- Founded
- Tabriz, IR Jan 1, 1947
- Last known activity
- May 1, 2025